Serum lipid profile of patients with genotype 1b hepatitis C viral infection in Japan

被引:40
|
作者
Moriya, K
Shintani, Y
Fujie, H
Miyoshi, H
Tsutsumi, T
Yotsuyanagi, H
Iino, S
Kimura, S
Koike, K
机构
[1] Univ Tokyo, Grad Sch Med, Dept Gastroenterol Internal Med, Bunkyo Ku, Tokyo 1138655, Japan
[2] St Marianna Univ, Sch Med, Dept Gastroenterol & Hepatol, Kawasaki, Kanagawa, Japan
[3] Univ Tokyo, Grad Sch Med, Dept Infect Dis Internal Med, Bunkyo Ku, Tokyo 1138655, Japan
关键词
apolipoprotein; hypocholesterolemia; steatosis; PROLIFERATOR-ACTIVATED RECEPTOR; CORE PROTEIN; HEPATOCELLULAR-CARCINOMA; TRANSGENIC MICE; VIRUS-INFECTION; STEATOSIS; INTERFERON; SECRETION; INCREASE; LIVER;
D O I
10.1016/S1386-6346(02)00309-1
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatitis C virus (HCV) infection is associated with the development of steatosis in the liver. Recently, infection with genotype 3a HCV has been reported to have a closer association with hepatic steatosis than that with genotype 1 or 2 HCV. Moreover, infection with genotype 3a HCV but not with genotype I has been shown to be associated with serum hypocholesterolemia or hypobetalipoproteinemia in European countries. We conducted a case control study to characterize the serum lipid profile in patients infected with genotype 1b HCV, which is the most prevalent HCV genotype in Japan. These patients had significantly lower serum cholesterol levels than those infected with HBV or genotype 2a HCV who had similar liver disease progression and body mass index. Further analysis of serum apolipoproteins revealed that not only apolipoprotein B but also apolipoprotein CII and apolipoprotein CIII levels were significantly reduced, while apolipoprotein AI, AII and E levels were similar in patients infected with genotype 1b HCV and those with HBV or genotype 2a HCV. These results indicate that, in Japan, infection with genotype 1b HCV is a cause of lipid metabolism disturbances, which may be associated with the pathogenesis of hepatitis C liver disease. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:371 / 376
页数:6
相关论文
共 50 条
  • [31] Increased risk of hepatocellular carcinoma in patients infected with hepatitis C genotype 1b
    Zein, NN
    Poterucha, JJ
    Gross, JB
    Wiesner, RH
    Therneau, TM
    Gossard, AA
    Wendt, NK
    Mitchell, PS
    Germer, JJ
    Persing, DH
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1996, 91 (12): : 2560 - 2562
  • [32] ELBASVIR/GRAZOPREVIR FOR HEPATITIS C VIRUS GENOTYPE 1b PATIENTS RECEIVING HEMODIALYSIS
    Liu, Chen-Hua
    Peng, Cheng-Yuan
    Fang, Yu-Ren
    Yang, Sheng-Shun
    Kao, Wei-Yu
    Lin, Cheng-Kuan
    Liu, Chun-Jen
    Lai, Hsueh-Chou
    Su, Wen-Pang
    Huang, Yi-Jie
    Chang, Chun-Chao
    Su, Tung-Hung
    Chen, Pei-Jer
    Chen, Ding-Shinn
    Kao, Jia-Horng
    HEPATOLOGY, 2019, 70 : 977A - 977A
  • [33] Daclatasvir plus asunaprevir in treatment-na?ve patients with hepatitis C virus genotype 1b infection
    Lai Wei
    Fu-Sheng Wang
    Ming-xiang Zhang
    Ji-dong Jia
    Alexey A Yakovlev
    Wen xie
    Eduard Burnevich
    Jun-qi Niu
    Yong Jin Jung
    xiang-Jun Jiang
    Min xu
    xin-Yue Chen
    qing xie
    Jun Li
    Jin-Lin Hou
    Hong Tang
    xiao-guang dou
    Yash gandhi
    Wen-Hua Hu
    Fiona McPhee
    Stephanie Noviello
    Michelle Treitel
    Ling Mo
    Jun deng
    World Journal of Gastroenterology, 2018, (12) : 1361 - 1372
  • [34] Daclatasvir and asunaprevir combination therapy for patients with chronic hepatitis C virus genotype 1b infection in real world
    Oh, Jae Young
    Kim, Byung Seok
    Lee, Chang Hyeong
    Song, Jeong Eun
    Lee, Heon Ju
    Park, Jung Gil
    Hwang, Jae Seok
    Chung, Woo Jin
    Jang, Byoung Kuk
    Kweon, Young Oh
    Tak, Won Young
    Park, Soo Young
    Jang, Se Young
    Suh, Jeong Ill
    Kwak, Sang Gyu
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2019, 34 (04): : 794 - 801
  • [35] Tailoring interferon dose and monitoring viral load in hepatitis C virus genotype 1b infected patients: a pilot study
    Colombatto, P
    Baldi, M
    Oliveri, F
    Randone, A
    Bonino, F
    Brunetto, MR
    DIGESTIVE AND LIVER DISEASE, 2000, 32 (03): : 211 - 216
  • [36] Viral Hepatitis B, C Infection and Genotype Distribution among Cholangiocarcinoma Patients in Northeast Thailand
    Barusrux, Sahapat
    Nanok, Chaiyachet
    Bhudhisawasdi, Vajarabhongsa
    Pairojkul, Chawalit
    Poovorawan, Yong
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 : 83 - 87
  • [37] Natural killer (NK) cell receptor genotype in a unique cohort of Irish women is associated with outcome of hepatitis C genotype 1B viral infection.
    O'Brien, C
    Gardiner, C
    Golden-Mason, L
    Hegarty, JE
    O'Farrelly, C
    HEPATOLOGY, 2004, 40 (04) : 448A - 448A
  • [38] Hepatic triglyceride lipase plays an essential role in changing the lipid metabolism in genotype 1b hepatitis C virus replicon cells and hepatitis C patients
    Shinohara, Yoshiyasu
    Imajo, Kento
    Yoneda, Masato
    Tomeno, Wataru
    Ogawa, Yuji
    Fujita, Koji
    Kirikoshi, Hiroyuki
    Takahashi, Junichiro
    Funakoshi, Kengo
    Ikeda, Masanori
    Kato, Nobuyuki
    Nakajima, Atsushi
    Saito, Satoru
    HEPATOLOGY RESEARCH, 2013, 43 (11) : 1190 - 1198
  • [39] Follow up chronic hepatitis C virus genotype 1b infection in a unique cohort.
    Curry, MP
    McKiernan, SM
    Reilly, M
    Nolan, N
    McDonald, G
    Kelleher, D
    Hegarty, JE
    HEPATOLOGY, 1999, 30 (04) : 267A - 267A